Nordhealth AS (6E5) Stock Statistics & Valuation Metrics

Nordhealth AS has a market cap or net worth of €161.48M. The enterprise value is €2.70B.

Nordhealth AS has 45,191,746 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nordhealth AS’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -20.43%.

The current PE Ratio of Nordhealth AS is ―. Nordhealth AS’s PEG ratio is ―.

In the last 12 months, Nordhealth AS had revenue of 50.29M and earned -12.54M in profits. Earnings per share was -0.16.

In the last 12 months, operating cash flow was -1.52M and capital expenditures -5.13M, giving a free cash flow of -6.64M billion.

Nordhealth AS pays an annual dividend of ―, resulting in a dividend yield of ―

Nordhealth AS upcoming earnings date is Aug 18, 2026, Before Open (Confirmed).

Nordhealth AS as a current ratio of 2.21, with Debt / Equity ratio of 0.00%

In the past 12 months, Nordhealth AS has paid 384.76K in taxes.

Nordhealth AS EV to EBITDA ratio is -166.66, with an EV/FCF ratio of -54.49.

Nordhealth AS has €14.96M in cash and marketable securities with €0.00 in debt, giving a net cash position of €14.96M billion.

Gross margin is 59.49%, with operating margin of -25.01%, and net profit margin of -24.94%.

The average price target for Nordhealth AS is ―, which is 11.43% higher than the current price. The consensus rating is ―